paracetamol sandoz 10 mg/ml infuusioneste, liuos
sandoz a/s sandoz a/s - paracetamolum - infuusioneste, liuos - 10 mg/ml - parasetamoli
pamolhot-c 750 mg / 300 mg porejauhe
orifarm healthcare a/s - ascorbic acid, paracetamol - porejauhe - 750 mg / 300 mg - parasetamoli
para-caps 500 mg kapseli, pehmeä
orion corporation - paracetamolum - kapseli, pehmeä - 500 mg - parasetamoli
parasetamoli ya 500 mg tabletti
galena pharma oy - paracetamol - tabletti - 500 mg - parasetamoli
carmustine medac (previously carmustine obvius)
medac gesellschaft für klinische spezialpräparate mbh - carmustine - hodgkin disease; lymphoma, non-hodgkin - antineoplastiset aineet - carmustine is indicated n adults in the following malignant neoplasms as a single agent or in combination with other antineoplastic agents and/or other therapeutic measures (radiotherapy, surgery): , brain tumours (glioblastoma, brain-stem gliomas, medulloblastoma, astrocytoma and ependymoma), brain metastases, secondary therapy in non-hodgkin’s lymphoma and hodgkin’s disease, as conditioning treatment prior to autologous haematopoietic progenitor cell transplantation (hpct) in malignant haematological diseases (hodgkin’s disease / non-hodgkin’s lymphoma).
azacitidine celgene
celgene europe bv - atsakitidiini - myelodysplastic syndromes; leukemia, myelomonocytic, chronic; leukemia, myeloid, acute - antineoplastiset aineet - azacitidine celgene is indicated for the treatment of adult patients who are not eligible for haematopoietic stem cell transplantation (hsct) with:intermediate 2 and high-risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss),chronic myelomonocytic leukaemia (cmml) with 10 29 % marrow blasts without myeloproliferative disorder,acute myeloid leukaemia (aml) with 20 30 % blasts and multi-lineage dysplasia, according to world health organisation (who) classification,aml with >30% marrow blasts according to the who classification.
mucoratio 200 mg poretabletti
teva b.v. - acetylcysteine - poretabletti - 200 mg - asetyylikysteiini
tramadol/paracetamol krka 37.5 mg / 325 mg tabletti, kalvopäällysteinen
krka, d.d., novo mesto - paracetamol, tramadol hydrochloride - tabletti, kalvopäällysteinen - 37.5 mg / 325 mg - tramadoli ja parasetamoli
tramadol/paracetamol krka 75 mg / 650 mg tabletti, kalvopäällysteinen
krka, d.d., novo mesto - paracetamol, tramadol hydrochloride - tabletti, kalvopäällysteinen - 75 mg / 650 mg - tramadoli ja parasetamoli
carmustine macure 100 mg kuiva-aine ja liuotin välikonsentraatiksi infuusionestettä varten, liuos
macure pharma aps - carmustine - kuiva-aine ja liuotin välikonsentraatiksi infuusionestettä varten, liuos - 100 mg - karmustiini